The content of this page is not yet available in English.
Publications récentes
Gaudreault E, Gosselin J. Leukotriene B4 Induces Release of Antimicrobial Peptides in Lungs of Virally Infected Mice. Journal of immunology (Baltimore, Md. : 1950) , 2008. 180: 6211-6221
Gaudreault E, Fiola S, Olivier M, Gosselin J. Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. Journal of virology, 2007. 81: 8016-24
Gaudreault E, Gosselin J. Leukotriene B(4)-Mediated Release of Antimicrobial Peptides against Cytomegalovirus Is BLT1 Dependent. Viral immunology, 2007. 20: 407-20
Savard M, Gosselin J. Epstein-Barr virus immunossuppression of innate immunity mediated by phagocytes. Virus research, 2006. 119: 134-45
Gosselin J, Borgeat P, Flamand L. Leukotriene B4 protects latently infected mice against murine cytomegalovirus reactivation following allogeneic transplantation. Journal of immunology (Baltimore, Md. : 1950) , 2005. 174: 1587-93
Gravel A, Dion V, Cloutier N, Gosselin J, Flamand L. Characterization of human herpesvirus 6 variant B immediate-early 1 protein modifications by small ubiquitin-related modifiers. The Journal of general virology, 2004. 85: 1319-28
Flamand L, Borgeat P, Lalonde R, Gosselin J. Release of anti-HIV mediators after administration of leukotriene B4 to humans. The Journal of infectious diseases, 2004. 189: 2001-9
Arsenault S, Gravel A, Gosselin J, Flamand L, Flamand L. Generation and characterization of a monoclonal antibody specific for human herpesvirus 6 variant A immediate-early 2 protein. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2003. 28: 284-90
Berry KA, Borgeat P, Gosselin J, Flamand L, Murphy RC. Urinary metabolites of leukotriene B4 in the human subject. The Journal of biological chemistry, 2003. 278: 24449-60
Gravel A, Tomoiu A, Cloutier N, Gosselin J, Flamand L. Characterization of the immediate-early 2 protein of human herpesvirus 6, a promiscuous transcriptional activator. Virology, 2003. 308: 340-53